Key result
Transapical thoracic endografting successfully excludes an SVG pseudoaneurysm while maintaining patency at 8 months.
Case Report (n=1)
Transapical deployment of a thoracic endograft is a feasible approach for excluding a saphenous vein graft proximal anastomotic pseudoaneurysm in patients with a prosthetic aortic valve.
Answers are grounded in this paper and cite their sources.
May offer an alternative exclusion strategy for SVG pseudoaneurysms in patients with prosthetic aortic valves; leaves open durability and safety in larger cohorts.
The authors describe the transapical deployment of a thoracic endograft to exclude a saphenous vein graft proximal anastomotic pseudoaneurysm following coronary artery bypass grafting (CABG) in a 63-year-old male with a prosthetic aortic valve. A standard thoracic endograft has been deployed via transapical access after percutaneous transluminal coronary angioplasty of the native vessel perfused by the patent CABG. The procedure was uneventful; an 8-month computed tomography scan showed complete exclusion of the pseudoaneurysm with patency of supra-aortic trunks.
No takes yet. Share an insight, caveat, or question.
Antonello et al. (2019) conducted a case report in Saphenous vein graft proximal anastomotic pseudoaneurysm (n=1). Transapical deployment of a thoracic endograft was evaluated on Exclusion of the pseudoaneurysm and patency of supra-aortic trunks. Transapical deployment of a thoracic endograft successfully excluded a saphenous vein graft pseudoaneurysm in a patient with a prosthetic aortic valve, with patency maintained at 8 months.
Synapse has enriched 10 related papers. Consider them for comparative context: